Choice Institutional Equities has reiterated its positive stance on Glenmark Pharma following a major licensing deal between ...

Glenmark Pharmaceuticals Ltd is quoting at Rs 2235, up 0.4% on the day as on 12:44 IST on the NSE. The stock is up 58.13% in last one year as compared to a 1.63% gain in NIFTY and a 8.9% gain in the ...

Pharma giants like Cipla, Glenmark, and Emcure are stepping into the booming skincare market, challenging beauty brands with ...

Maruti Suzuki India: The company announced standardization of six airbags in Ertiga and Baleno. This will result in an ...

Discover 5 large cap stocks including Vodafone Idea and Paytm that surged up to 32% in one month - explore the top gainers ...

ICICI Bank(Rs. 714.67 crore), Tech Mahindra(Rs. 679.82 crore), Angel One(Rs. 628.56 crore), Adani Wilmar(Rs. 466.27 crore), ...

Firms downgrade 2025 outlook, isocyanate start-up launches, hydrogen projects advance, and more ...

The FDA cracked down on two plants in India and one in Korea in separate recently released reports, citing issues ranging ...

The Nifty Pharma index closed 0.32 per cent down at 22593.9. Benchmark NSE Nifty50 index ended up 16.25 points at 25212.05, ...

As long as the Nifty 50 remains below 25,250, consolidation may continue, with 25,100–25,000 acting as the support zone.

The NSE Nifty 50 ended 16.25 points or 0.06% higher at 25,212.05, while the BSE Sensex closed 63.57 points or 0.08% up at 82,634.48.

In June, mutual funds in India made huge investments in specific sectors, showing where investors see strong potential and confidence. These investments highlight changing market trends and growing ...